Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Arkwright

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
Journal of Leukocyte Biology|September 15, 2020
Neutrophil dysfunction triggers inflammatory bowel disease in G6PC3 deficiencyAnu Goenka, John A Doherty, Tariq Al-Farsi, et al.
Dermatology and Therapy|July 22, 2023
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 YearsElaine C Siegfried, Eric L Simpson, Michael J Cork, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2016
Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from functionYifang Gao, Peter D Arkwright, Rachel Carter, et al.
Arthritis and Rheumatism|January 1, 2008
Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndromeBelinda Nedjai, Graham A Hitman, Nasim Yousaf, et al.
Paediatric Drugs|December 18, 2022
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic DermatitisAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Journal of Clinical Immunology|September 25, 2015
Astute Clinician Report: A Novel 10 bp Frameshift Deletion in Exon 2 of ICOS Causes a Combined Immunodeficiency Associated with an Enteritis and HepatitisNic Robertson, Karin R Engelhardt, Neil V Morgan, et al.
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
The New England Journal of Medicine|October 2, 2004
Autoimmune lymphoproliferative syndrome with somatic Fas mutationsEliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, et al.
Dermatology and Therapy|September 26, 2023
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic DermatitisMichael J Cork, Diamant Thaçi, Lawrence F Eichenfield, et al.
Journal of Leukocyte Biology|June 9, 2005
Highly glycosylated alpha1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophilsKim Theilgaard-Mönch, Lars C Jacobsen, Thomas Rasmussen, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Journal of Leukocyte Biology|September 15, 2020
Neutrophil dysfunction triggers inflammatory bowel disease in G6PC3 deficiencyAnu Goenka, John A Doherty, Tariq Al-Farsi, et al.
Dermatology and Therapy|July 22, 2023
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 YearsElaine C Siegfried, Eric L Simpson, Michael J Cork, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2016
Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from functionYifang Gao, Peter D Arkwright, Rachel Carter, et al.
Arthritis and Rheumatism|January 1, 2008
Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndromeBelinda Nedjai, Graham A Hitman, Nasim Yousaf, et al.
Paediatric Drugs|December 18, 2022
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic DermatitisAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Journal of Clinical Immunology|September 25, 2015
Astute Clinician Report: A Novel 10 bp Frameshift Deletion in Exon 2 of ICOS Causes a Combined Immunodeficiency Associated with an Enteritis and HepatitisNic Robertson, Karin R Engelhardt, Neil V Morgan, et al.
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
The New England Journal of Medicine|October 2, 2004
Autoimmune lymphoproliferative syndrome with somatic Fas mutationsEliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, et al.
Dermatology and Therapy|September 26, 2023
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic DermatitisMichael J Cork, Diamant Thaçi, Lawrence F Eichenfield, et al.
Journal of Leukocyte Biology|June 9, 2005
Highly glycosylated alpha1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophilsKim Theilgaard-Mönch, Lars C Jacobsen, Thomas Rasmussen, et al.
Pageof 17